unknown
Stage
4
Investors
About
Multimmune is a clinical-stage biopharmaceutical company developing novel immunotherapies for cancer and infectious diseases. Their therapies leverage heat shock proteins (HSPs).
Explore multimmune's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.